Abstract
A REVIEW ON INCIDENCE OF TYPES OF BREAST CANCER AND ADVERSE REACTIONS OF CHEMOTHERAPY IN CANCER PATIENTS

G.Y. Srawan Kumar*, B. Bhavani Bai*, Y. Vijaya Lakshmi and Dr. D. Rama Brahma Reddy

ABSTRACT

Cancer is also called as Neoplasm or Tumor, is a mass of tissue formed as a result of abnormally excessive, uncoordinated autonomous, purposeless proliferation of cells. Several types of cancers are there depending upon origin, type of tissue involved, grading system. “BREAST CANCER” is the type of cancer that starts in the breast (based on origin). It can start in one or both breasts. The breast is an organ that sits on top of the upper ribs and chest muscles. There is a left and right and each one has mainly gland, ducts, and fatty tissue. Most breast cancers are carcinomas (based on tissue type). Breast cancers are also classified by certain types of proteins or genes each cancer might make. These proteins are estrogen receptors and progesterone receptors and the HER-2 gene or protein. These proteins can help to decide the stage of the cancer and treatment option. Now a day, breast cancer is the most frequently diagnosed life threatening cancer in women leading to death among women. The aim of this article is to determine and describe the incidence of types of breast cancer and adverse reactions in Breast Cancer patients who were taking the chemotherapeutic drugs involved in their treatment options. These symptoms may vary in terms of occurrence, severity and distress and be effect the treatment or illness.

Keywords: Cancer, Breast cancer, Chemotherapy, Radiation therapy, Mastectomy, Carcinoma, Biopsy.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2022 Issue has been successfully launched on 1 NOVEMBER 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT